Hologen, Sysmex Form AI Venture To Analyse Blood Test Data

Key takeaways

Hologen and Japan's Sysmex have created joint venture Saibogen to use generative AI on routine blood test data, aiming to extract more insights without new equipment.

• Saibogen will apply Hologen’s Large Medicine Models to Sysmex analysers handling about three billion blood counts annually
• The venture targets researchers and clinicians, offering software‑only products through Sysmex devices
• Initial offerings are for research use only, requiring no additional instruments or reagents

Summarised automatically by AI from the original article by Bernama. AI can make mistakes, so check the original for details.